ArticleJournal of oncology2021

Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway.

Jing Ke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.